James J Loughlin - Net Worth and Insider Trading
James J Loughlin Net Worth
The estimated net worth of James J Loughlin is at least $4 Million dollars as of 2025-05-05. James J Loughlin is the Director of Celgene Corp and owns about 40,436 shares of Celgene Corp (CELG) stock worth over $4 Million. James J Loughlin is also the Director of PDS Biotechnology Corp and owns about 1,281 shares of PDS Biotechnology Corp (PDSB) stock worth over $1,768. Details can be seen in James J Loughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James J Loughlin has not made any transactions after 2019-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James J Loughlin
James J Loughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James J Loughlin owns 2 companies in total, including PDS Biotechnology Corp (PDSB) , and InspireMD Inc (NSPR) .
Click here to see the complete history of James J Loughlin’s form 4 insider trades.
Insider Ownership Summary of James J Loughlin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 2017-03-06 | director |
| NSPR | InspireMD Inc | 2012-09-21 | director |
James J Loughlin Latest Holdings Summary
James J Loughlin currently owns a total of 2 stocks. Among these stocks, James J Loughlin owns 40,436 shares of Celgene Corp (CELG) as of February 7, 2019, with a value of $4 Million and a weighting of 99.96%. James J Loughlin also owns 1,281 shares of PDS Biotechnology Corp (PDSB) as of March 6, 2017, with a value of $1,768 and a weighting of 0.04%.
Latest Holdings of James J Loughlin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2019-02-07 | 40,436 | 108.24 | 4,376,793 |
| PDSB | PDS Biotechnology Corp | 2017-03-06 | 1,281 | 1.38 | 1,768 |
Holding Weightings of James J Loughlin
James J Loughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, James J Loughlin has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 23,466 shares on February 7, 2019, which brought James J Loughlin around $2 Million.
According to the SEC Form 4 filings, James J Loughlin has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the acquisition of 150 shares on March 6, 2017, which cost James J Loughlin around $27,720.
Insider Trading History of James J Loughlin
- 1
James J Loughlin Trading Performance
GuruFocus tracks the stock performance after each of James J Loughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Loughlin is 17.99%. GuruFocus also compares James J Loughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Loughlin within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James J Loughlin's insider trading performs compared to the benchmark.
Performance of James J Loughlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 3.74 | | | | | |
James J Loughlin Ownership Network
Ownership Network List of James J Loughlin
Ownership Network Relation of James J Loughlin
James J Loughlin Owned Company Details
What does PDS Biotechnology Corp do?
Who are the key executives at PDS Biotechnology Corp?
James J Loughlin is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .
PDS Biotechnology Corp (PDSB) Insider Trades Summary
Over the past 18 months, James J Loughlin made no insider transaction in PDS Biotechnology Corp (PDSB). Other recent insider transactions involving PDS Biotechnology Corp (PDSB) include a net purchase of 15,061 shares made by Stephen C. Glover , and a net purchase of 15,060 shares made by Gregory Gene Freitag .
In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 30,121 shares, with a net purchase of 30,121 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 30,121 shares were bought by its insiders, resulting in a net purchase of 30,121 shares.
PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDS Biotechnology Corp Insider Transactions
James J Loughlin Mailing Address
Above is the net worth, insider trading, and ownership report for James J Loughlin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James J Loughlin's mailing address is: New York Ny 10177.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
